Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04400227

Preventing Youth Substance Use With Family Talk

Pilot Study of Family Talk to Prevent Youth Substance Use

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Boston Medical Center · Academic / Other
Sex
All
Age
12 Years
Healthy volunteers
Not accepted

Summary

Family Talk, an evidence-based parent-youth dyadic intervention, is a promising approach to improving substance use outcomes for high-risk families, and its structure lends itself to delivery by existing personnel within an Office-Based Addiction Treatment (OBAT) model of care. The investigators propose a single-arm pilot study with 25 parent-youth dyads through which a rapid cycle performance improvement approach will be employed to adapt and optimize the content and delivery of the embedded Family Talk prevention strategy. The investigators will field-test relevant baseline and outcome measures and will use qualitative methodology to identify key modifications to the intervention and generate hypotheses for how the prevention strategy may impact youth and family outcomes and prevent youth substance use. Information from this study will inform a subsequent pilot randomized controlled trial of the intervention to prevent substance use for youth whose parents are in recovery from SUD (substance use disorder).

Conditions

Interventions

TypeNameDescription
OTHERFamily TalkFamily Talk is an evidence-based, parent-youth dyadic approach that uses psychoeducation and skills building to help families make meaning of a parent's adversity, increase resilience, and improve family functioning. The Family Talk model comprises two components: the first involves a series of cognitive-behavioral techniques to bolster problem solving and communication skills among family members; the second involves a facilitated family meeting to develop a shared narrative for discussing each family member's experience of the parent's illness.

Timeline

Start date
2022-07-01
Primary completion
2023-06-01
Completion
2023-06-01
First posted
2020-05-22
Last updated
2022-07-13

Source: ClinicalTrials.gov record NCT04400227. Inclusion in this directory is not an endorsement.